Craig D. Shriver, MD, FACS

Colonel, Medical Corps, United States Army 
Director, John P. Murtha Cancer Center, WRNMMC 
Program Director, National Capital Consortium (NCC), General Surgery, WRNMMC 
Professor of Surgery, Uniformed Services University of Health Sciences (USUHS) 
Chief, General Surgery Service, WRNMMC 


COL Craig D. Shriver, FACSExpertise
General Surgical Oncology, Breast Cancer, Pancreatic Cancer, Whipple Procedure, Gastric Cancer, Sarcoma, Colon and Rectal Cancer, Thyroid and Parathyroid Diseases and Cancers, Bile Duct Cancer, Melanoma, Sentinel Lymph Node surgery 

Education
  • Bachelor of Science Biochemistry (1980), Albright College (Reading, PA) Cum Laude Outstanding Alumni Award (2003)
  • Doctor of Medicine (1984) Temple University School of Medicine (Philadelphia, PA) Alpha Omega Alpha
Residencies
  • General Surgery (1989), Walter Reed Army Medical Center (WRAMC), (Washington, DC) 
    General Graves B. Erskine Award for Outstanding Resident
Fellowship
  • Surgical Oncology (1993), Memorial Sloan-Kettering Cancer Center (New York, NY)
Certifications
  • Diplomate, National Board of Medical Examiners (1985-2013)
  • Diplomate, American Board of Surgery (2009-2021)
Bio
COL Craig Shriver, a native of Reading PA, earned his Bachelor’s Degree in Biochemistry from Albright College, and continued on to acquire his Medical Degree from Temple University School of Medicine. Upon his graduation he was commissioned in the US Army Medical Corps (1984). His post graduate training included his surgical internship and residency at the Walter Reed Army Medical Center (WRAMC). Dr. Shriver was selected for advanced fellowship training in surgical oncology at the Memorial Sloan-Kettering Cancer Center. 

After completing his fellowship he was assigned to the WRAMC as a staff general surgeon. In 1995 he was assigned as the Chief of Surgical Oncology, and in 1998 became the Director of the Surgery Residency Program, and the Chief of General Surgery in 2001. 

February 2000 he was selected by the command to become Director of the congressionally-mandated Clinical Breast Care Project (CBCP), a military-civilian coalition providing excellent clinical care and cutting-edge breast cancer research. This research project has been funded over $100 million since its inception, and has amassed one of the world’s most extensive human biorepositories of breast cancers and tissues, which are used by researchers to study breast cancer and its treatment. He was named Interim Director of the Cancer Center at the Walter Reed National Military Medical Center in Bethesda (WRNMMC) in September 2011, and then named Director of the John P. Murtha Cancer Center at the WRNMMC in November 2012. 

COL Shriver’s military education includes completion of the Advanced Officer Course, and graduating with honors (top 10% of class) from the Command and General Staff College in June 2000. His operational assignments include a two-year tour at Fort Bragg, North Carolina, and direct surgical support of four overseas combat military operations (tours). He deployed in support of Operation Just Cause (the liberation of Panama in 1989, serving as Chief Triage Officer and Surgeon for the Forward Surgical Team of the 5th MASH. He then went on to become Surgeon of the 307th Medical Battalion of the 82nd Airborne Division, providing far-forward surgical support during Operation Desert Shield and Desert Storm (1990-1991), and earning the coveted Combat Medical Badge. He was decorated by his command for his direct surgical support of the medical response to the terrorist attack against the Pentagon on 11 September 2001. Since the terrorist attacks of 11 September 2001, as chief of General Surgery at the nation’s largest military hospital, he has led his surgeons in the treatment of over 7,500 patients from Operations Iraqi Freedom and Enduring Freedom (Afghanistan). In 2007, COL Shriver served in Afghanistan (along the Pakistan border) with the 1-91 Cavalry, 173rd Airborne, winning the coveted “Order of the Spur” award from his cavalry unit, for gallant and intrepid service under fire on the front lines of combat in Afghanistan. COL Shriver also was decorated with the Combat Action Badge (CAB) during that tour, for service under fire in direct engagement with enemy forces. COL Shriver just completed his fourth combat tour, second in Afghanistan, returning on 20 February 2011. 

Other military awards include the Legion of Merit, Meritorious Service Medal, Joint Services Commendation Medal, Army Commendation Medal with two oak leaf clusters, and the Civilian Outstanding Service Medal. He was awarded the prestigious “A” Designator Award from the Surgeon General, given to only a select few military physicians who are the leaders of healthcare in the Army. He was awarded the Order of Military Medical Merit, given to “civilian or military physicians who meet the highest standard of “citizen-soldier-physician.” In 2008 Dr. Shriver was promoted to the rank of Professor of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Shriver in 2010 was elected into the prestigious American Surgical Association, the oldest and most premier of all surgical societies in the world. Dr. Shriver has been an author on three separate articles published in the prestigious New England Journal of Medicine, and has also been an author on an article in the world’s most premier research publication, NATURE, in September 2012. 

Research Interests
Breast Cancer, Pancreatic Cancer; Outcomes Research: Endocrine Malignancies 

Research Projects
Multiple 

Oral Presentations, Posters, Abstracts
Over 300 

Selected Publications
  1. Graeber GM, Seyfer AE, Shriver CD, Awan M. "Desmoid Tumor of the Paraspinous Muscle Involving the Chest Wall." Military Medicine 150 (8): 458. 1985.
  2. Shriver CD. "Major Site Review: In-depth Study of Breast Cancer." Walter Reed Army Medical Center 1992 Cancer Program Report: 28-41. 1992.
  3. Shriver CD, Karpeh MS, Brennan MF. "Extended Lymph Node Dissection in Gastric Cancer." Surgical Oncology Clinics of North America 2 (1): July 1993.
  4. Caravalho J, Balingit AG, Rivera-Rodriguez JE, Shriver CD, Koops MK. "Localization of an Ectopic Parathyroid Adenoma by Double-Phase Technetium-99m Sestamibi Scintigraphy." The Journal of Nuclear Medicine, 36(10): 1840-2. October 1995.
  5. Hann LE, Fong Y, Shriver CD, Botet JF, Brown KT, Klimstra DS, Blumgart LH. “Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability?” Journal of Ultrasound Medicine. January 1996;15(1):37-45.
  6. Shriver CD, Editor. "Surgical and Staging Procedures of the Breast”: The Manual of the CALGB May 1996.
  7. Shriver CD. "Mastectomy (Simple; Modified Radical; Prophylactic)." In Editor Shriver CD. Surgical and Staging Procedures of the Breast: The Manual of the CALGB. Published, p. 22-24, May 1996.
  8. Morgan TO, Schenkman NS, Peppas DS, Rueda-Pedraza EM, Shriver CD, Costabile RA. "Pelvic clear cell carcinoma in a 14-year-old boy." The Journal of Urology, 155: 2062-2063, June 1996.
  9. Shriver CD, Miner T, Jaques D, Maniscalco-Theberge M, Deavers M, Balingit A, Krag D, Diehl L. “Sentinel node biopsy using a non-blue dye technique: results in 50 patients with melanoma and breast cancer.” Proc Annu Meet Am Soc Clin Oncol 16: A1530. 1997.
  10. Stojadinovic A, Shriver CD, Casler JD, York G, Gaertner E, Jaques DP. “Endoscopic laser excision of ectopic pyriform sinus parathyroid adenoma.” Archives of Surgery, 133: 101-103. 1998.
  11. Miner T, Shriver CD, Jaques DP, Schutt D. “The Department of Defense experience in perioperative testing for metastatic disease in patients with breast cancer.” The Breast Journal, 4(2): 84-88. 1998.
  12. Ader DN, Browne MW, Shriver CD. “Chronic cyclical breast pain and associated health care utilization, breast cancer risk, and psychosocial issues.” Psychosomatic Medicine, 60(1): 102. 1998.
  13. Moreno AJ, Jimenez CE, Maredia R, Shriver CD, Ward DL, Hetz SP, Simcic KJ. “Ectopic laryngeal parathyroid adenoma detected by SPECT sestamibi imaging.” Clinical Nuclear Medicine, 23(5): 332 – 333. May 1998.
  14. Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN. “Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer.” Annals of Surgical Oncology, 5(4): 315-321, June 1998.
  15. Allen PJ, Stojadinovic A, Shriver CD, Jaques DP. "Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma." Annals of Surgical Oncology, 5(5): 437-441, July/August 1998.
  16. Krag DN, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Beitsch P, Whitworth P, Foster R, Dowlatshahi K. “The Sentinel Node in Breast Cancer: A Multicenter Validation Study.” The New England Journal of Medicine 339; 14: 941-946. 1 October 1998.
  17. Burch HB, Shakir F, Fitzpatrick TR, Jaques DP, Shriver CD. “Diagnosis and treatment of autonomously-functioning thyroid nodules.” Thyroid 8; 10: 871 – 880. October 1998.
  18. Miner TJ, Shriver CD, Flicek P, Miner FC, Jaques DP, Maniscalco-Theberge ME, Krag D. "Guidelines for the safe use of radioactive materials during the localization and resection of the sentinel lymph node." Annals of Surgical Oncology 6(1):75-82, January/February 1999.
  19. Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN. “Sentinel lymph node biopsy for breast cancer: Patient eligibility based on type of previous biopsy.” The American Surgeon 65; 493-499. June 1999.
  20. Allen P, Shriver CD. “Desmoid Tumors of the Chest Wall.” Seminars in Thoracic and Cardiovascular Surgery, 11(3); 264-269. July 1999.
  21. Miner T, Shriver CD. “Sentinel Node Biopsy Using a Non-blue dye technique: Results in 148 patients with melanoma and breast cancer.” ASCO Proceedings, 1999. Abstract #479.
  22. Miner TJ, Shriver CD, Flicek P, Miner FC, Jaques DP, Maniscalco-Theberge ME, Krag D. "Guidelines for the safe use of radioactive materials during the localization and resection of the sentinel lymph node." Abstracted in Breast Diseases: A Yearbook Quarterly. September 1999.
  23. Grobmyer SR, Guillem JG, O’Riordain DS, Woodruff JM, Shriver C, Brennan MF. “Colonic manifestations of Multiple Endocrine Neoplasia Type 2B: report of 4 cases.” Diseases of the Colon and Rectum, 42(9):1216-9, September 1999.
  24. Kulas PM, Hwang I, Starnes BW, Balingit AG, Shriver CD. “Incidental detection of carcinoid with technetium-99m labeled CEA monoclonal antibody scintigraphy during evaluation of metastatic colon cancer.” Clinical Nuclear Medicine, 24(12):978-9, December 1999.
  25. Conner WC, Shriver CD. “Symptomatic Adult Polycystic Liver Disease.” Journal of the American College of Surgeons 191: 3: 332, September 2000.
  26. da Silva AD, O’Donnell S, Gillespie D, Goff J, Shriver C, Rich N. “Malignant Carotid Body Tumor: A Case Report.” Journal of Vascular Surgery, 32 (4); 821-823, October 2000.
  27. Rehrig ST, Marshall S, Meghoo C, Peoples, Jr. GE,Shriver CD. “Five Year Qualitative Results of Isolated Cryosurgical Ablation for Hepatic Malignancy at Walter Reed Army Medical Center.” Current Surgery 58: 1; 81-85, January/February 2001.
  28. Stocker DJ, Foster SS, Solomon BL, Shriver CD, Burch HB. “Thyroid Cancer yield in patients with Graves’ Disease selected for surgery on the basis of “cold” sciniscan defects.” Submitted to Journal of Endocrinology and Metabolism, February 2001.
  29. Ringel MD, Anderson J, Souza SL, Burch HB, Tambascia M,Shriver CD, Tuttle RM. “Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.” Mod Pathol, 14(4):289-96, April 2001.
  30. Shriver CD. Review of Atlas of Cancer Surgery (textbook, edited by Bloom, Beattie, Harvey). Oncology, June 2001.
  31. Stojadinovic A, Allen PJ,Shriver CD. “Metastatic carcinoid tumour presenting as hepatic encephalopathy.” HPB (Oxford). 2002;4(1):47-50. PMID: 18333153 [PubMed] {Journal of the International Hepato Pancreato Biliary Assocuiation}
  32. Stocker DJ, Foster SS, Solomon BL, Shriver CD, Burch HB. “Thyroid cancer yield in patients with Graves' disease selected for surgery on the basis of cold scintiscan defects.” Thyroid, 12(4):305-11. April 2002. PMID: 12034055 [PubMed]
  33. Hueman M, Scanlan B, White P, Golarz S, Peoples G, Shriver CD, Maniscalco-Theberge M. “The effect of changing gamma count threshold on sentinel lymph node accuracy.” Curr Surg, 59(3):313-7. May-June 2002. PMID: 16093154 [PubMed] May/June 2002.
  34. Miner TJ, Jaques DP, Shriver CD. “A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy.” Ann Surg Oncol, 9(7):696-703. August 2002. PMID: 12167585 [PubMed]
  35. Stojadinovic A, Allen PJ, Shriver CD. “Metastatic carcinoid tumour presenting as hepatic encephalopathy.” HPB (Oxford). 2002;4(1):47-50. PMID: 18333153 [PubMed]
  36. Ellsworth DE,Shriver CD, Ellsworth RE, Deyarmin B, Somiari RI. “Laser Capture Microdissection of Paraffin-Embedded Tissues.” BioTechniques 34:42-46. January 2003.
  37. Danforth, Jr. DN, Cowan K, Altemus R, Merino M, Chow C, Berman A, Chaudhry U, Shriver CD, Steinberg S, Zujewski J. “Preoperative FLAC/GCSF Chemotherapy for Stage II Breast Cancer: A Prospective Randomized Trial.” Accepted - Annals of Surgical Oncology, February 2003.
  38. Ellsworth RE, Ellsworth DL, Lubert S, Hooke JA, Somiari R, Shriver CD. “High-Throughput Loss of Heterozygosity Mapping in 26 Commonly Deleted Regions in Breast Cancer.” Cancer Epidemiol Biomark Prev, vol. 12, pp. 915-919. 2003e.
  39. Jordan R, Somiari S, Malicki L, Lubert S, Brzeski H, Hu H, Shriver CD, Ratavn R, Ellsworth D, Ellsworth R, Somiari R. “Performance and bioinformatic evaluation of overlapping vaiable length oligonucleotide probes used in spotted microarrays.” Transactions of the Integrated Biomedical Informatics and Enabling Technologies Symposium Journal, 1: 15-24, August 2003.
  40. Ellsworth RE, Ellsworth DL, Love B, Deyarmin B, Mittal V, Lubert SM, Somiari SI, Shriver CD. “Tumor Suppressor Gene Localization and Clinical Outcome Prediction through Global Loss of Heterozygosity Analysis.” Submitted Genes, Chromosomes, and Cancer, August 2003.
  41. Somiari RI, Sullivan A, Russell S, Somiari S, Hi H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J, Shriver C. “High throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.” Proteomics, 10(3); 1863-1873. October 2003.
  42. Brzeski H, Katenhusen RA, Sullivan AG, Russell S, George A, Somiari R,Shriver CD. “Albumin Depletion Method for Improved Plasma Glycoprotein Analysis by Two-dimensional Difference Gel Electrophorsis.” BioTechniques, 35:1128-1132. December 2003.
  43. Gurney JM, Woll MM, Storrer CE, Fisher CM, Shriver CD, Ponniah S, Peoples GE. “In Vivo Peptide Specific CD8+ Clonal Expansion and Epitope Spreading in Breast Cancer Patients Receiving a HER2/neu Peptide Vaccine.” Proc Am Assoc Cancer Res 2003; 44:396-7
  44. Gurney JM, Woll MM, Storrer CE, Fisher CM, Shriver CD, Ponniah S, Peoples GE. “In vivo monitoring of the immune response in breast cancer patients receiving a HER2/neu peptide vaccine.” J Am Coll Surg (suppl), 197:S81-82. 2003.
  45. Arciero C, Somiari S, Shriver C, Brzeski H, Jordan R, Hu H, Ellsworth D, Somiari RI. “Functional Relationship and Gene Ontology Classification of Breast Cancer Biomarkers.” International Journal of Biological Markers, vol. 18, no. 4, pp. 241-272. 2003.
  46. Ellsworth R, Ellsworth D, Lubert S, Hooke JA, Somiari R, Shriver CD. “High-Throughput Loss of Heterozygosity Mapping in 26 Commonly Deleted Regions in Breast Cancer.” Cancer Epidemiol Biomark Prev, vol. 12, pp. 915-919. 2003e.
  47. Hueman MT, Gurney JM, Storrer CE, Kotula L, Jackson KA, Wilson M, McLeod DG, Moul JW, Shriver CD, Ponniah S, Peoples GE. “Immunological Studies of Vaccine-Specific Immune Responses in Breast and Prostate Cancer Patients Receiving a HER2/neu (E75) Vaccine.” J Immunother 2003;26:S8
  48. Shriver CD, Russell S, Sillivan A, Somiari S, Jordon R, Hooke JA, Somiari R. “Proteomics Analysis of Invasive Breast Cancer and Associated Lymph Nodes by 2-Demensional Difference Gel Electrophoresis (2D-DIGE).” Annals of Surgical Oncology (ASO). 2003.
  49. Peoples GE, Arciero C, Adair C, Shriver CD. “Presentations from the Walter Reed Army Medical Center. Case 2: a mass in the head of the pancreas.” Oncology (Williston Park), 18(2):140-142, February 2004. No abstract available. PMID: 15008053 [PubMed]
  50. Woll M, Fisher C, Ryan G, Gurney J, Storrer C, Ioannides C, Shriver C, Moul J, Mcleod D, Ponniah S, Peoples G. “Direct measurement of Peptide Specific CD8(+) T Cells Using HLA-A2:Ig Dimer for Monitoring the In Vivo Immune Response to a Her2/neu Vaccine in Breast and Prostate Cancer Patients.” Journal of Clinical Immunology, 24(4):449-61. July 2004. PMID: 15163902 [PubMed]
  51. Arciero CA, Peoples GP, Stojadinovic A, Shriver CD. “The utility of a rapid parathyroid assay in Uniglandular, Multiglandular and recurrent parathyroid disease.” The American Surgeon, July 2004.
  52. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Hooke JA, Shriver CD. “Outer breast quadrants demonstrate increased levels of genomic instability.” Ann Surg Oncol, 11(9):861-8. September 2004. Epub 16 August 2004. PMID: 15313734 [PubMed]
  53. Hu H, Brzeski H, Hutchins J, Ramaraj M, Qu L, Xiong R, Kalathil S, KatoR, Tenkillaya S, Carney J, Redd R, Arkalgudvenkata S, Shahzad K, Scott R, Cheng H, Meadow S, McMichael J, Sheu SL, Rosendale D, Kvecher L, Ahern S, Yang S, Zhang Y, Jordan R, Somiari SB, Hooke JA, Shriver CD, Somiari RI, Liebman MN. “Biomedical Informatics: Development of a Comprehensive Data Warehouse for Clinical and Genomic Breast Cancer Research.” Pharmacogenomics, 7: 933-941. 5 October 2004.
  54. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Shriver CD. “Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.” Breast Cancer Res Treat, 88(2):131-139. November 2004. PMID: 15564796 [PubMed]
  55. Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD. “Genomic instability in histologically normal breast tissues: implications for carcinogenesis.” Lancet Oncol, 5(12):753-8. Review. December 2004. PMID: 15581548.
  56. Somiari SB, Shriver CD, He J, Parikh K, Jordan R, Hooke J, Hu H, Deyarmin B, Lubert S, Malicki L, Heckman C, Somiari RI. “Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.” Cancer Genet Cytogenet, 155(2):108-18. December 2004. PMID: 15571796.
  57. Jordan R, Somiari S, Malicki L, Lubert S, Brzeski H, Hu H, Shriver CD, Ravatn R, Ellsworth DL, Ellsworth RE, Somiari R. “Performance and Bioinformatic Evaluation of Overlapping Variable Length Oligonucleotide Probes Used in Spotted Microarrays.” 2004. Transactions of the Integrated Biomedical Informatics & Enabling Technologies Symposium Journal, vol. 1, pp. 15-24.
  58. Mittendorf E, Heuman M, Storrer C, Shriver C, Ponniah S, Peoples G. “Evaluation of the Cd107a Cytotoxicity Assay for the Detection of Cytolytic CD8 Cells Recognizing Her2/neu Vaccine Peptides.” J Surg Research 121 (2): 327(#P65), 2004.
  59. Sullivan AG, Russell S, Arciero C, Deyarmin B, Hooke J, Shriver C, Somiari R. “Differential Protein Expression Analysis in Human Breast Cancer Using Tissue Samples and Pure Cell Populations obtained by LMD Using 2D-DIGE, MALDI, and Q-Tof MS/MS.” Proceedings of the ASMS, 2004a.
  60. Ellsworth D, Ellsworth R, Liebman M, Hooke J, Shriver C. “Genomic Instability in Non-neoplastic Breast Tissues: Implications for Carcinogenesis.” Lancet Oncology, vol. 5, pp. 753-758, 2004c.
  61. Ellsworth D, Ellsworth R, Love B, Deyarmin B, Lubert S, Mittal V, Hooke J, Shriver C. “Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability.” Ann Surg Oncol, vol. 11, pp. 861-868, 2004e.
  62. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert S, Mittal V, Shriver CD. “Genomic Patterns of Allelic Imbalance in Disease Free Tissue Adjacent to Primary Breast Carcinomas.” 2004f. Breast Cancer Res Treat, vol. 88, pp. 131-139.
  63. Somiari S, Shriver CD, He J, Parikh K, Jordan R, Hooke J, Hu H, Deyarmin B, Lubert S, Malicki L, Heckman C, Somiari R. “Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.” Cancer Genetics and Cytogenetics, 155; 2: 108-118. 2004.
  64. Somiari S, Shriver C, Heckman C. “Plasma Concentration and Activitiy of Matrix Metalloproteinase 2 and 9 patients with Breast Disease, Breast Cancer and at Risk of Developing Breast Cancer.” Cancer Letters, vol. Accepted for Publication, 2004.
  65. Somiari S, Somiari RI, Hooke J, Hu H, Bronfman L, Bombatch J, Deyarmin B, Heckman C, Kush M, Williamson E, Garguilo G, Mittal V, Jacobs N, Hapner A, Liebman M, Shriver C. “Establishment and Management of a Comprehensive Biorepository for Integrated High Throughput Genomics and Proteomics Research.” TIBETS, vol. 1, pp. 131-143. 2004e.
  66. Ellsworth R, Ellsworth D, Neatrour D, Deyarmin B, Lubert S, Sarachine M, Brown P, Hooke J, Shriver C. “Allelic Imbalance in Primary Breast Carcinomas and Metastatic Tumors of the Axillary Lymph Nodes.” Molecular Cancer Research, Feb 2005, 3,71. doi: 10.1158/1541-7786.MCR-04-0180.
  67. Somiari RI, Somiari S, Russell S, Shriver CD. “Proteomics of breast carcinoma” J Chromatogr B Analyt Technol Biomed Life Sci, 815(1-2):215-25. Review. February 2005. PMID: 15652811.
  68. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg, 62(2):253-7. March-April 2005. PMID: 15796952.
  69. Stojadinovic A, Nissan A, Gallimidi Z, Lenington S, Logan W, Zuley M, Yeshaya A, Shimonov M, Melloul M, Fields S, Allweis T, Ginor R, Gur D, Shriver CD. “Electrical Impedance Scanning for the Early Detection of Breast Cancer in Young Women: Preliminary Results of a Multicenter Prospective Clinical Trial.” JCO, 2703-2715. 20 April 2005.
  70. Maskery S, Zhang Y, Jordan R, Hu H, Shriver C, Hooke J, Liebman M. “A Novel Computational Analysis of Heterogeneity in Breast Tissue.” Proceedings from the 18th IEEE Symposium on Computer Based Medical Systems. Dublin Ireland. pp. 395-400. 24-25 June 2005.
  71. Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. “Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.” Breast Cancer Res Treat, 92 (1): 85-93, July 2005. PMID: 15980996.
  72. Peoples GE, Gurney JM, Hueman MT, Woll MM, Ryan GB, Storrer CE, Fisher C, Shriver CD, Ioannides CG, Ponniah S. “Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients.” J Clin Oncol, 20October 2005; 23(30):7536-45. Epub 12 September 2005. PMID: 16157940.
  73. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD. “Quantitative Analysis of Active and Total MMP2 and MMP9 in Serum of Individuals with Breast Disease, Breast Cancer, and at Low or High Risk of Developing Breast Cancer.” Cancer Research, October 2005.
  74. Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD. “Timing of critical genetic changes in human breast disease. Ann Surg Onco. December 2005;12(12):1054-60. Epub 10 October 2005. PMID: 16228814.
  75. Dehqanzada ZA, Storrer CE, Foley RJ, Harris KA, Jama YH, Shriver CD, Ponniah S, Peoples GE. “Elevated serum MCP-1 level is associated with favorable clinical prognostic factors and immune response and can be induced by a HER2/neu (E75) vaccine in breast cancer patients.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58, December 2005.
  76. Becker TE, Ellsworth RE, Ellsworth DL, Deyarmin B, Hooke JA, Shriver CD. “Genomic alterations in axillary lymph node metastases are associated with clinical outcomes in patients with breast cancer.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58, December 2005.
  77. Field LA, Love BJ, Kane J, Deyarmin B, Hooke JA, Ellsworth RE, Shriver CD. “Differential gene expression in normal breast tissue from African American and Caucasian women.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58, December 2005.
  78. Sun W, Zhang Y, Hooke J, Brzeski H, Shriver CD, Liebman MN, Hu H. “Between educational level and breast cancer.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  79. Maskery S, Zhang Y, Hu H, Hooke J, Shriver CD, Liebman M. “Variation in breast disease co-occurrence frequencies between pre- and post-menopausal women.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  80. Zhu L, Ru Q, Silberman J, Jacobs N, Shriver CD. “Peptide breast cancer biomarkers detectable through blood tests.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  81. Ellsworth RE, Ellsworth DL, Love B, Hoffman LR, Deyarmin B, Hooke JA, Shriver CD. “Genomic alterations as a pathological aid to classifying ductal carcinoma in situ.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  82. Ru Q, Zhu L, Silberman J, Jacobs N, Shriver CD. “Serum proteome of breast cancer: a group of proteins related to the invasive stage.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  83. Yang Y, Heckman C, Shriver CD, Becker T, Liebman MN, Brzeski H. “Gene expression profiles in white blood cells of patients with breast cancer - correlation with detectability of tumor by mammographic screening.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  84. Zhang Y, Zhu L, Ru Q, Brzeski H, Liebman MN, Hooke J, Shriver CD. “Molecular profiling of human breast cancer with serum mass spectrum data.” Breast Cancer Research and Treatment, 94 (Suppl 1), S58. December 2005.
  85. Ellsworth DL, Russell S, Deyarmin B, Sullivan A, Brzeski H, Somiari R, Shriver CD. “Laser-Assisted Microdissection in Proteomic Analyses.” The Proteomics Protocols Handbook, J. Walker, ed, Humana Press, pp. 59-66. 2005
  86. Somiari R, Russell S, Somiari S, Sullivan A, Ellsworth D, Brzeski H, Shriver C. "Difference gel electrophoresis in a high throughput environment.” The Proteomics Protocols Handbook, J. Walker, ed., Humana Press, pp. 223-238. 2005.
  87. Hu H, Copper J, Everly RI, Heckman C, Jordan R, Somiari R, Hooke JA, Shriver CD, Liebman M. “Can Circulating Matrix Metalloproteinases be Predictors of Breast Cancer? - A Neural Network Modeling Study.” Advances In Natural Computation, 3610 edn, Wang L, Chen K, & Ong YS, eds., Springer-Verlag, pp. 1039-2042. 2005a.
  88. Dehqanzada ZA, Storrer CE, Hueman MT, Foley R, Harris K, Jama Y, Shriver CD, Ponniah S, Peoples GE. “Assessing Serum Cytokine Profiles in Breast Cancer Patients Receiving a HER2/neu Vaccine Using Luminex® Technology.” Ann Surg Oncol 2005;12:S47 (#P20)
  89. Dehqanzada ZA, Storrer CE, Hueman MT, Foley RJ, Harris KA, Jama YH, Kao TC, Shriver CD, Ponniah S, Peoples GE. Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients. Clin Cancer Res, 12(2):478-86. 15 January 2006. PMID: 16428490.
  90. Somiari SB, Shriver CD, Heckman C, Olsen C, Hu H, Jordan R, Arciero C, Russell S, Garguilo G, Hooke J, Somiari RI. “Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer.” Cancer Lett, 233(1):98-107. 20 February 2006. PMID: 16473671.
  91. Stojadinovic A, Moskovitz O, Gallimidi Z, Fields S, Brooks AD, Brem R, Mucciola RN, Singh M, Maniscalco-Theberge M, Rockette HE, Gur D, Shriver CD. “Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer.” Breast Cancer Res Treat, 97(2):179-89. Epub 21 Februrary 2006. May 2006. PMID: 16491309.
  92. Seebach J, Ellsworth RE,Shriver CD. “Molecular Profiling of Breast Cancer.” Seminars in Breast Disease, Vol 9, Issue 1, 19-24. March 2006.
  93. Mittendorf EA, Gurney JM, Storrer CE,Shriver CD, Ponniah S, Peoples GE. “Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.” Surgery, 139(3):407-18. March 2006. PMID: 16546506.
  94. Somiari SB, Shriver CD, Heckman C, Olsen C, Hu H, Jordan R, Arciero C, Russell S, Garguillo G, Hooke JA, Somiari RI. “Plasma Concentrations and Activity of Matrix Metalloproteinase 2 and 9 in Patients with Breast Disease, Breast Cancer and At Risk of Developing Breast Cancer.” EL Sevier Ireland Ltd, P 98-107. 2006.
  95. Somiari S, Heckman C, Olsen C, Jordan R, Russell S, Shriver C. “Circulating MMP2 and MMP9 in Breast Cancer-Potential Role in Classification of Patients into Low Risk, High Risk, Benign Disease and Breast Cancer Categories.” International Journal of Cancer (Accepted). 2006b.
  96. Yang Y, Heckman C, Shriver C, Becker T, Liebman M, Brzeski H. “Gene Expression Profiles in White Blood Cells of Patients with Breast Cancer - Correlation with Dectectability of Tumor by Mammographic Screening.” Breast Cancer Res Treat, vol. 94, no. Suppl 1, p. S59-S60. 2006.
  97. Seebach J, Ellsworth R, Shriver CD. “A Molecular Profiling of Breast Cancer.” Seminars in Breast Disease, Vol 9, No. 1, pp. 19-24 – DOI: 10.1053/j.sembd.2006.10.005.
  98. Maskery S, Zhang Y, Jordan R, Hu H, Hooke J, Shriver C, Liebman M. “Co-Occurrence Analysis for Discovery of Novel Breast Pathology Patterns.” IEEE Transactions on Information Technology in Biomedicine, vol. 10, no. 3, p. In-Press. 2006.
  99. Mittendorf EA, Storrer CE, Foley RJ, Harris K, Jama Y, Shriver CD, Ponniah S, Peoples GE. “Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.” Cancer, 106(11):2309-17. 1 June 2006. PMID: 16596621.
  100. Ru QC, Zhu LA, Silberman J, Shriver CD. “Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry. Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry.” Mol Cell Proteomics, 5(6):1095-104. Epub 17 March 2006. June 2006. PMID: 16546996.
  101. Hueman MT, Stojadinovic A, Storrer CE, Foley RJ, Gurney JM, Shriver CD, Ponniah S, Peoples GE. “Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.” Breast Cancer Res Treat, July 2006;98(1):17-29. Epub 7 June 2006. PMID: 16758122.
  102. Maskery SM, Zhang Y, Jordan RM, Hu H, Hooke JA, Shriver CD, Liebman MN. “Co-occurrence analysis for discovery of novel breast cancer pathology patterns.” IEEE Trans Inf Technol Biomed, 10(3):497-503. July 2006. PMID: 16871717.
  103. Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. “Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.” Ann Surg Oncol, August 2006;13(8):1085-98. Epub 24 July 2006. PMID: 16865596.
  104. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD. “Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories.” Int J Cancer,119(6):1403-11. 15 September 2006. PMID: 16615109.
  105. Hueman MT, Stojadinovic A, Storrer CE, Dehqanzada ZA, Gurney JM, Shriver CD, Ponniah S, Peoples GE. “Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.” Cancer Immunol Immunother, February 2007;56(2):135-46. Epub 17 June 2006. PMID: 16783576.
  106. Yang S, Guo X, Yang YC, Papcunik D, Heckman C, Hooke J, Shriver CD, Liebman MN, Hu H. “Detecting outlier microarray arrays by correlation and percentage of outliers spots.” Cancer Inform, 24 February 2007;2:351-60. PMID: 19458777.
  107. Wu H, Zhu K, Jatoi I, Shah M, Shriver CD, Potter J. “Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.” Breast Cancer Res Treat. March 2007;101(3):317-24. Epub 4 July 2006. PMID: 16821080.
  108. Dehqanzada ZA, Storrer CE, Hueman MT, Foley RJ, Harris KA, Jama YH, Shriver CD, Ponniah S, Peoples GE. “Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.” Oncol Rep, March 2007;17(3):687-94. PMID: 17273752.
  109. Stojadinovic A, Nissan A, Protic M, Adair CF, Prus D, Usaj S, Howard RS, Radovanovic D, Breberina M, Shriver CD, Grinbaum R, Nelson JM, Brown TA, Freund HR, Potter JF, Peretz T, Peoples GE. “Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.” Ann Surg, June 2007;245(6):846-57. PMID: 17522508.
  110. Bronfman L, Shriver CD, Gutchell E. “The Clinical Perspective.” Chapter 2, Biomedical Informatics: A Translational Approach, August 2007.
  111. Stojadinovic A, Henry LR, Peoples GE, Mittendorf EA, Lenington S, Nissan A, Shriver CD. “Satisfaction with breast cancer screening and future screening participation.” Med Sci Monit, October 2007;13(10):CR422-9. PMID: 17901848.
  112. Zhang Y, Sun W, Gutchell EM, Hu H, Liebman MN, Shriver CD, Mural RJ. “An issue tracking system to facilitate the enhancement of clinical data quality in the clinical breast care project.” AMIA Annu Symp Proc, 11 October 2007:1173. PMID: 18694269.
  113. Callaghan KA, Becker TE, Ellsworth DL, Hooke JA, Ellsworth RE, Shriver CD. “Genomic instability and the development of metastatic lymph node tumors.” Ann Surg Oncol, November 2007;14(11):3125-32. Epub 25 July 2007. PMID: 17653592.
  114. Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE, Moroni M. “HYOU1/Orp150 expression in breast cancer.” Med Sci Monit, November 2007;13(11):BR231-239. PMID: 17968289.
  115. Ellsworth RE, Ellsworth DL, Love B, Patney HL, Hoffman LR, Kane J, Hooke JA, Shriver CD. “Correlation of levels and patterns of genomic instability with histological grading of DCIS.” Ann Surg Oncol, November 2007;14(11):3070-7. Epub 5 June 2007. PMID: 17549568.
  116. Ellsworth RE, Hooke JA, Love B, Ellsworth DL, Shriver CD. “Contribution of Chromosomal Alterations to the Development of Poorly-Differentiated Invasive Breast Carcinomas.” Am Jour of Surg Path, December 2007.
  117. Ellsworth RE, Ellsworth DL, Love B, Hoffman LR, Deyarmin B, Patney HL, Hooke JA, Shriver CD. “Allelic Imbalance Effectively Differentiates Ductal Carcinoma In Situ by Histological Grade.” Annals Surg Oncol. 14:3070-3077, 2007.
  118. Ellsworth RE, Hooke JA, Love B, Kane JL, Patney HL, Ellsworth DL, Shriver CD. “Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors.” Breast Cancer Res Treat, January 2008;107(2):259-65. Epub 10 March 2007.PMID: 17351743.
  119. Amin A, Shriver CD, Henry LR, Lenington S, Peoples GE, Stojadinovic A. “Breast cancer screening compliance among young women in a free access healthcare system.” J Surg Oncol, 1 January 2008;97(1):20-4. PMID: 17918226.
  120. Stojadinovic A, Nissan A, Shriver CD, Mittendorf EA, Akin MD, Dickerson V, Lenington S, Platt LD, Stavros T, Goldstein SR, Moskovitz O, Gallimidi Z, Fields SI, Yeshaya A, Allweis TM, Manassa R, Pappo I, Ginor RX, D'Agostino RB, Gur D. “Electrical impedance scanning as a new breast cancer risk stratification tool for young women.” J Surg Oncol, 1 February 2008;97(2):112-20. PMID: 18050282.
  121. Callaghan KA, Ellsworth RE, Ellsworth DL, Shriver CD. “HER2 in the Era of Molecular Medicine: A Review.” Curr Cancer Ther Rev, Feb 2008:vol 4/1 pp 57-65.
  122. Becker TE, Ellsworth RE, Deyarmin B, Patney HL, Jordan RM, Hooke JA, Shriver CD, Ellsworth DL. “The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.” Ann Surg Oncol, April 2008;15(4):1056-63. Epub 2 February 2008. PMID: 18246400.
  123. Maskery SM, Hu H, Hooke J, Shriver CD, Liebman MN. “A Bayesian derived network of breast pathology co-occurrence.” J Biomed Inform, April 2008;41(2):242-50. Epub 1 January 2008. PMID: 18262472.
  124. Croft DT Jr, Jordan RM, Patney HL, Shriver CD, Vernalis MN, Orchard TJ, Ellsworth DL. “Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays.” J Mol Diagn, May 2008;10(3):249-57. Epub 10 April 2008. PMID: 18403606.
  125. Ellsworth RE, Zhu K, Bronfman L, Gutchell V, Hooke JA, Shriver CD. “The Clinical Breast Care Project: an important resource in investigating environmental and genetic contributions to breast cancer in African American women.” Cell Tissue Bank, June 2008;9(2):109-20. Epub 11 October 2007. PMID: 17929197.
  126. Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD. “Chromosomal alterations associated with the transition from in situ to invasive breast cancer.” Ann Surg Oncol, September 2008;15(9):2519-25. Epub 12 July 2008. PMID: 18622645.
  127. Bronfman L, Shriver CD. “A New Paradigm for Integrating Translational Research into Comprehensive Breast Care: The Walter Reed Army Medical Center / Windber Research Institute Experience.” Seminars in Breast Disease Journal, Sep 2008; vol 11/3, pp 160-163.
  128. Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Love B, Hooke JA, Shriver CD. “Amplification of HER2 is a marker for global genomic instability.” BMC Cancer, 14 October 2008;8:297. PMID: 18854030.
  129. Weyandt J, Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL. “Environmental chemicals and breast cancer risk--a structural chemistry perspective.” Curr Med Chem, 2008;15(26):2680-701. Review. PMID: 18991630.
  130. Ellsworth RL, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, Love B, Shriver CD. “Breast Metastasis Gene Signature Identification of a Gene Expression Breast Cancer Nodal Metastasis Profile.” Clinical and Experimental Metastasis Journal, Mar 2009, vol 26/3, pp 205-213.
  131. Stojadinovic A, Peoples GE, Jurgens JS, Howard RS, Schuyler B, Kwon KH, Henry LR, Shriver CD, Buckenmaier CC. “Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial.” Lancet Oncol, September 2009;10(9):849-54. Epub 5 August 2009. PMID: 19664956.
  132. Holliday C, Rummel S, Hooke JA, Shriver CD, Ellsworth DL, Ellsworth RE. “Genomic instability in the breast microenvironment? A critical evaluation of the evidence.” Expert Rev Mol Diagn, October 2009;9(7):667-78. Review. PMID: 19817552.
  133. Ellsworth RE, Hooke JA, Love B, Ellsworth DL, Shriver CD. “Molecular changes in primary breast tumors and the nottingham histologic score.” Pathol Oncol Res, December 2009;15(4):541-7. Epub 5 February 2009. PMID: 19194786.
  134. Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, Love B, Shriver CD. “A gene expression signature that defines breast cancer metastases.” Clin Exp Metastasis, 2009;26(3):205-13. Epub 27 December 2008. PMID: 19112599.
  135. Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL. “Genomic Heterogeneity of Breast Tumor Pathogenesis.” ClinMedOnc 2009;3;77-85
  136. Ellsworth DL, Ellsworth RE, Hooke JA, Shriver CD. “Human Genetic and Structural Genomic Variation: Would Genome Wide Association Studies be The Solution of Cancer Complexity Like Alexander The Great for The ‘Gordian Knot?” AnnSurgOncol 16:776-777. doi: 10.1245/s10434-008-0255-x. 2009.
  137. Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD. “Chromosomal Alterations in Pure Nonneoplastic Breast Lesions: Implications for Breast Cancer Progression.” Ann Surg Oncol, 27 January 2010. [Epub ahead of print] PMID: 20107913.
  138. Stojadinovic A, Eberhardt C, Henry L, Eberhardt J, Elster E, Peoples G, Nissan A, Shriver CD. “Development of a Bayesian Classifier for Breast Cancer Risk Stratification: A Feasibility Study.” Eplasty, vol 10, pp 203-216, 29 March 2010, ISSN: 1937-5719. Open Science Co. LLC, Springfield, Illinois.
  139. Ellsworth RE, Field LA, Love B, Kane JL, Hooke JA, Shriver CD. “Breast Cancer Metastasis Gene Signature: the Search for the Holy Grail.” J Clin Oncol, May 2010; vol 28/15, suppl 1075.
  140. Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL. “Breast Cancer in the Personal Genomics Era.” Current Genomics, 2010; 11:146-161.
  141. Buckenmaier III CC, Kwon KH, Howard RS, McKnight GM, Shriver CD, Fritz WT, Garguilo GA, Joltes KH, Stojadinovic A. “Double-Blinded, Placebo-Controlled Prospective Randomized Trial Evualating the Efficacy of Paravertebral Block With and Without Contiuous Paravertebral Block Analgesia in Outpatient Breast Cancer Surgery.” Pain Medicine 2010; 11:790-799.
  142. Zhou J, Brinckerhoff C, Lubert S, Yang K, Saini J, Hooke JA, Mural RJ, Shriver CD, Somiari S. Analysis of Matrix Metalloproteinase-1 Gene Polymorphisma and Expression in Benign and Malignant Breast Tumors, Cancer Invest 2011 Nov;29(9):599-607.
  143. Hu H, Correll M, Kvecher L, Osmond M, Clark J, Bekash A, Schwab G, Gao D, Gao J, Kubatin V, Shriver CD, Hooke JA, Maxwell LG, Sheldon JG, Liebman MN, Mural RJ. “A Data Warehouse for Translational Research Featuring an Extensible Data Model and a User-friendly Interface.” J Biomed Info, Dec 2011; vol 44/6, pp 1004-1019.
  144. Field LA, Love B, Deyarmin B, Hooke JA, Shriver CD, Ellsworth RE. “Identification of Differentially expressed genes in African American Compared to Caucasian Women.” Cancer, Mar 2012, vol 118/5, pp 1334-1344. doi: 10.1002/cncr.26405.
  145. PNNL, Walter Reed & Windber. “PNNL, Walter Reed & Windber to scour triple negative breast cancer for leads on diagnostics and drugs”, EurekAlert! and Newswise, June 2012.
  146. Iida J, Dorchak J, Lehman JR, Clancy R, Luo C, Chen Y, Somiari S, Ellsworth RE, Hu H, Mural R, Shriver CD. “FH535 inhibited migration and growth of breast cancer cells.” PLOS ONE, Sept 2012; 7(9) e44418.
  147. The Cancer Genome Atlas Network. “Comprehensive molecular portraits of human breast tumours.” Nature, 23 Sep 2012;490(7418):61-70. Epub 2012 23 Sep. doi:10.1038/nature11412.

Last Updated 11/4/2019